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Summary.-Alveolar macrophage (AM) phagocytic activity and glucose metabolism
were evaluated during lung tumour growth in adult rats challenged i.v. with 105
viable Walker 256 tumour cells. Phagocytosis was estimated by the in vitro uptake
of 14C-labelled Pseudomonas aeruginosa and glucose oxidation was evaluated by 14C02
production from 1-14C-glucose. AM were harvested by lung lavage from rats prior
to and at 7 and 21 days following i.v. tumour-cell challenge. Macroscopic lung tumour
nodules were not observed by 7 days after tumour challenge. However, 3 weeks
after tumour challenge, tumour nodules were clearly identifiable on the surfaces
of the lungs. One week after the i.v. tumour challenge a marked increase in the
number of AM was evident. The in vitro phagocytosis of 14C-labelled Pseudomonas
aeruginosa was unaltered at that time, but became progressively depressed thereafter.
Three weeks after tumour challenge, this decrease in phagocytic activity was evident
when cells were incubated in normal serum, and was furtheri ntensified by serum
obtained from tumour-bearing animals. Glucose oxidation by AM in either the
resting condition or during bacterial phagocytosis was clearly decreased at both
1 and 3 weeks following i.v. tumour challenge. These findings indicate that the
growth of pulmonary metastases is associated with a depression of alveolar macro-
phage bacterial phagocytic capacity, perturbations in serum opsonic activity and
distinct alterations in macrophage energy metabolism. The metabolic dysfunction
may impair pulmonary macrophage host defences against lung tumour growth.
THE LUNG represents a major target
for the lodgment of tumour cells following
the i.v. tumour-cell challenge or the
haematogenous dissemination of tumour
cells from a primary tumour site (Baserga
et al., 1960; van den Brenk, Moore and
Sharpington, 1971). Following the i.v.
administration of radiolabelled tumour
cells, such cells are preferentially localized
within the microcirculation of the lung,
where most of them are rapidly destroyed
(Fisher and Fisher, 1967; Fidler, 1970;
Sadler and Alexander, 1976). A small
percentage of the tumour cells trapped
in the lung escape destruction and
penetrate into the alveolar spaces
and proliferate (Cliffton et al., 1971).
The growth and proliferation of lung
tumour colonies from circulating tumour
cells suggests that a critical fraction
of these cells is able to escape local
tumour surveillance mechanisms.
The role of the reticuloendothelial
system (RES) or macrophage system
in cellular defence against neoplastic
cells is well recognized (Levy and Whee-
lock, 1974). Tumour-cell killing, mediated
bynon-specifically activated macrophages,
has been demonstrated in a variety of in
vitro assay systems (Alexander and Evans,
1971; Hibbs, Lambert and Remington,
1972; Keller, 1973), and is undoubtedly
active in the intact host. Many studies
have emphasized the importance of inti-
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mate cell cointact between the macrophage
and tumour target cell as a critical pre-
requisite to the cytotoxic mechanism of
the macrophage, in addition to the
maintenance of cellular metabolic capa-
city. An important role for circulating
humoral factors has been suggested in
the recognition of tumour cells by host
macrophages (Di Luzio, 1975; Saba and
Antikatzides, 1975). Alterations in plasma
opsonin or humoral recognition-factor
activity has been demonstrated in experi-
mental animals and in cancer patients,
but its specific relevance to macrophage
anti-tumour surveillance mechanisms re-
mains to be determined (Di Luzio, 1975;
Saba and Aintikatzides, 1975, 1976; Megi-
rian, Saba and Stephenson, 1 976).
Although the alveolar macrophage is
recognized as the major cellular defence
mechanism in the lower respiratory tract
(Green and Kass, 1964) there are few
data oIn the role of mononuclear phago-
cytes of the lung in defence against
lung tumour growth. Pulmonary cellular
anti-tumour defence mechanisms may be
impaired during the rapid growth of
surviving tumour cells in the lung, and
this impairment mav be a critical factor
allowing for the dissemination and con-
tinued local growth of neoplastic cells.
The balance between tumour-surveillance
mechanisms and tumour-cell load may
be critical to the initial development of
tumour colonies after tumour challenge,
but once established, the growing tumour
may feed back and further undermine
local defence mechanisms. To illuminate
this )roblem, we have studied the func-
tional stability ofthe alveolar macrophage
with respect to phagocytosis, response
to an opsonic stimulus, and glucose
metabolism, during the growth and spread
of lung tumour noduiles.
MATERIALS AND METHOD)S
Tuiiour-cell inoculation. Male Sprague-
Dawtley rats weighing 60-70 g and about
22-30 days of age served as donors. Wzalker
256 carcino-sarcoma tumour-bearing donor
rats wvere originally obtained from Micro-
biological Associates, Inc. (Bethesda, Mary-
land) and the tumour was subsequently
maintained by serial intramuscular trans-
plantation at 10-12 day intervals (Saba and
Antikatzides, 1975). Tumour donors were
anaesthetized by light ether anaesthesia
and the tumour mass was rapidly excised
under sterile conditions in a UV trans-
plantation unit. The viable peripheral portion
of the tumour mass was minced in sterile
saline and passed through a No. 8, 177yum-
pore microsieve. The cell suspension collected
was analysed for viability by dye exclusion.
Male adult rats weighing 250-300 g were
used as recipients in all studies of alveolar
macrophage function. Under light ether
anaesthesia, adult recipients received 105
viable tumour cells i.v. in a volume of
0-2 ml sterile saline and control rats were
injected with 0-2 ml sterile saline.
Alveolar macrophage collection.-Alveolar
macrophages (AM) were collected from
control rats and from rats at 1, 2 or 3 weeks
following i.v. challenge with tumour cells.
In this collection procedure, rats were
anaesthetized by i.p. sodium pentobarbital
(3 0 mg/100 g) and AM were obtained by
repeated lung lavage with a 0.2% EDTA-
supplemented 0-15M saline solution (pH
7.4) maintained at 37°C as previously
described (Gudewicz, Saba and Coulston,
1976a). Whole blood was collected by inferior
vena eava puncture prior to lung lavage,
and used as a source of experimental serum.
AM were washed twice in Hanks' balanced
salt solution (HBSS) without glucose (pH
7.4) at 4°C. Differential cell counts were
made w%vith Wright-Giemsa staining and
cell viability was determined by trypan-blue
exclusion. Total cell counts of the lung
lavage were performed in duplicate by
routine haemocytometry. Parallel studies in
02 consumption also confirmed the viability
of the alveolar macrophages harvested by
this technique (Gudewicz et al., 1976a, b).
Lung-tumour colony determination.-Im-
mediately following macrophage collection
the lungs were excised and the total number
of macroscopically visible tumour nodules
(colonies) on the surface of the lungs was
quantified as previously described (van den
Brenk et al., 1976). The number of lung
tumour colonies varied somewhat between
animals in each experimental group. The i.v.
challenge of 105 viable tumour cells wasP. W. GUDEWICZ AND T. M. SABA
the maximum tumour dose to produce
>95%/ survival 30 days after tumour-cell
injection. This dose was used as the experi-
mental model in order to guarantee survival
over the 3-week experimental period.
AM phagocytosis.-Phagocytosis by AM
harvested from tumour-challenged or control
animals was measured in vitro by the uptake
of 14C-labelled Pseudomonas aeroginosa as
previously described (Gudewicz et al., 1976a).
Phagocytosis was initiated by the addition
of 2-0 ml of AM suspension (5-10 x 106
AM/ml) in HBSS to 0 5 ml of radiolabelled
P. aeruginosa (5-10 x 108 bacteria/ml). Each
flask was supplemented with 10% fresh rat
serum pooled from either tumour-cell-injected
or saline-injected control groups. Flasks
were incubated at 37°C in a Dubnoff meta-
bolic shaker bath under room air atmosphere
at 60 rev/min for 30 min. Following incuba-
tion, AM were collected by centrifugation
at 500g for 10 min at 4°C and washed
twice in 0-900 NaCl to remove non-ingested
bacteria. Washed-cell pellets were digested
in 0 5 ml of 0-2N NaOH for 4 h at 80°C.
The resulting cell digest was cooled to room
temperature and neutralized by the addition
of 0-1 ml of 500 acetic acid, and duplicate
aliquots were added to 10 ml of Scintiverse
(Fisher Scientific Co., Rochester, NY).
Samples were counted in an Isocap 300
liquid scintillation system (Amersham/Searle
Co., Arlington Heights, IL) and phagocytic
uptake was expressed as ct/min of 14C-
labelled P. aeruginosa/30 min/107 AM.
AM glucose oxidation.-Glucose oxidation
via hexose monophosphate shunt (HMPS)
was quantified by 14CO2 collection from
1-14C-glucose, using AM as previously de-
scribed (Gudewicz et al., 1976b). A suspension
of 3-0 ml of AM (2-0 x 107 AM/ml) in HBSS
was added to metabolic flasks containing
5-5 mM glucose, 12-5% fresh rat serum and
0-5 ,uCi of 1-14C-glucose (New England Nu-
clear, Boston, MA) with a total final volume
of 5-0 ml. Comparisons were made between
cells obtained from control and tumour-
bearing rats when incubated in serum
obtained from the various groups. Flasks were
incubated with or without heat-killed P.
aeruginosa (bacteria: macrophage ratio =
10: 1) for 60 min at 37°C, and the reaction
was terminated by the addition of 1-0 ml
of 6N H2804. At termination, the flasks
were incubated for an additional 15 min,
and the 14CO2 evolved was trapped in
scintillation vials on filter paper containing
0-3 ml of hyamine hydroxide. A volume
of 1-5 ml of 040o 1,5-diphenyl-oxazole and
0-01% 1,4-bis [2(5-phenyl-oxazoly')]benzene
in toluene was added and the vials -were
counted in the liquid scintillation system.
Counting efficiency was 65-700o and the
activity was expressed as ct/min of 14CO2
evolved/60 min/107 AM.
RESULTS
The temporal development of macro-
scopic lung tumour nodules in response
to i.v. tumour-cell challenge is illustrated
in Table I. Macroscopic lung tumour
TABLE I. The Development of Visible
Lung Tumour Nodules in Adult Rats
Following an i.v. Injection of Wralker
256 Carcinoma Cells
Time after i.v.
tumour-cell injection*
(weeks)
1
2
3
% with imacroscopic
lunig tumotulr
no(dllest
0 (0/24)
67 (16/24)
75 (18/24)
* Each group consiste(d of at least 12 rats chal-
lengedl i.v. with a (lose of 105 viable tutmour cells.
t Tumour colonies (listinctly visible andl quianti-
fiable on the surface of the lung.
nodules were first observed 2 weeks after
tumour-cell injection and, by 3 weeks,
75%0 of the recipients demonstrated large
macroscopic tumour nodules (2-10 nod-
ules/rat) on the surface of the lungs.
Parallel studies revealed that adult rats
injected with the same number of tumour
cells survived 30-40 days, with extensive
tumours apparent in the lungs, kidneys,
and lymph nodes.
The influence of tumotur growth on
the yield of alveolar macrophages (AM)
recovered by lung lavage from recipients
is presented in Table II. A significant
and consistent increase in the number
of AM lavaged from tumour-challenged
recipients was observed after onie week
(P < 0.001), prior to the appearance of
detectable macroscopic lung tumours.
This pattern of increased yield remained
elevated during the second and third
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TABLE II.-Alveolar Macrophage (AM)
Recovery by Lavage as a Function of
Time After i.v. Injection of Rats with
Walker 256 Carcinoma Cells
Time after i.v. injection
(weeks)
Controls
1
2
3
AM/rat
(mean x 106±s.e.)
10-3+0-5
16-7±0-6t
16-5±0-5t
16 9±O07t
* Each group has data averaged from 4 experi-
ments with 6 rats in each (total of 24 rats). Injected
animals were given 105 viable tumour cells and
controls received the saline diluent.
t Significantly different (P < 0-001) from con-
trol.
week, possibly representing a response
to the proliferation of lung tumour
colonies. Cell viability was greater than
95% at all intervals measured (cell
differentials of lavage fluid from tumour-
challenged groups revealed a predomin-
antly mononuclear macrophage cell popu-
lation). Tumour cells were excluded from
all lung-lavage cell counts of macrophage
yields.
In vitro phagocytic activity of lung
macrophages one week after i.v. tumour-
cell challenge is presented in Table III.
Bacterial phagocytosis by AM harvested
from tumour-challenged recipients was
compared with that of AM from control
animals in the presence of fresh rat
serum. Macrophages harvested one week
after tumour challenge demonstrated no
functional impairment of bacterial phago-
cytosis in the presence of serum from
control groups. Serum from the tumour-
challenged gro'ps supported comparable
levels of bacterial phagocytosi§ by either
control AM or AM harvested one week
after i.v. tumour challenge. Thus there
was no humoral deficit of opsonic factors
for bacterial phagocytosis in the serum
of tumour-challenged animals at this
time. Additionally, these data suggest
the lack at this time of an AM-depressant
factor in the serum.
In contrast, a defect in the bacterial
phagocytic uptake by AM was seen 3
weeks after tumour challenge, when lung
tumour nodules were clearly evident
(Table III). Macrophage capacity for
bacterial phagocytosis was significantly
depressed in AM from animals with
lung tumour nodules, relative to control
AM in the presence of pooled rat serum.
Serum pooled from tumour recipients 3
weeks after tumour challenge was signifi-
cantly less effective in supporting bacterial
phagocytosis by AM from control rats.
The combination of AM from tumour-
bearing rats and serum from tumour-
TABLE III.-In vitro Phagocytosis of 14C-labelled Pseudomonas aeruginosa by Alveolar
Macrophages (AM)
AM phagocytosis (ct/min/30 min/107 cells)*
Serum source
Series A
Control
1 week after tumour
challenge
Series B
Control
3 weeks after tumour
challenge
Control AM
(mean±s.e.) % of controlt
5272+ 161
5855± 170
72774-395
6095i 78$
100
111
100
83
Tumour-challenged AM
(mean±s.e.)
5435+ 111
5866+ 123
6383+115$
5817±46$
* 10-20 x 106 AM were incubated with 14C-labelled P8eudomonas aerugino8a (bacteria: cell ratio or 100: 1) in a total volume of 4-0 ml at 37°C in the presence of 10% serum from either control animals- 3 weeks after tumour challenge. Each flask was supplemented with 50-70,000 ct/min of labelled bacteria. Each group contains data averaged from 4 experiments. 8-12 rats were challenged with 105 viable tumour cells in each experiment.
t Control in each series (A or B) was the level of phagocytosis when control AM were incubated in control
serum.
Values significantly less (P < 0 05) than the controls.
% of controlt
103
111
87
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FiG. Glucose oxidation from 1-14C-glucose
by alveolar macrophages harvested 1 and
3 weeks after i.v. injection with 105 Walker-
256 carcinoma cells. Metabolism was
studied in the resting non-phagocytizing
(0) state and in association with bacterial
phagocytosis (*). Each point represents
the mean Is.e. of 3 experiments.
bearing rats had the least phagocytic
activity.
In an attempt to determine whether
specific aspects of macrophage energy
metabolism were altered prior to or
during the decline in phagocytic capacity
observed with lung-tumour growth, glu-
cose oxidation by alveolar macrophages
was examined in vitro in the absence or
presence of bacterial phagocytosis. The
Figure illustrates the 14CO2 production
from 1-14C-glucose by AM harvested prior
to and at one and three weeks after i.v.
tumour challenge. Macrophage oxidation
of 1-14C-glucose was markedly depressed,
with non-phagocytizing cells as well as
during bacterial phagocytosis, when the
macrophages studied were harvested one
week after tumour challenge. The de-
pression of glucose oxidation by AM
was significant (P < 0 001) and persisted
3 weeks after tumour-cell injection.
Table IV demonstrates the effect of
serum pooled from lung-tumour-bearing
rats (2 and 3 weeks after tumour-cell
injection) on the oxidation of 1_14C_
glucose by macrophages. Control AM
showed comparable levels ofglucose oxida-
tion, in the resting state, in the presence
of normal serum or serum harvested
after tumour challenge. The marked in-
crease in glucose oxidation seen in normal
cells during bacterial phagocytosis was
not evident when the bacterial challenge
was made in the presence of serum
from tumour-bearing rats. This observa-
tion suggests that a deficiency in serum
factor(s) supporting phagocytosis may
limit the extent of bacterial phagocytosis,
an event which is the stimulus for aug-
mented glucose oxidation via the hexose-
monophosphate shunt. The increase in
TABLE IV. Levels of Glucose Oxidation by AM Harvested from Control and Tumour-
bearing Rats in Serum from Control or Tumour-bearing Rats
Serum in
medium
Control
Tumour bearer
Bacterial
phagocytosis
+
Glucose oxidation* (ct/min 14CO2/60 min/107 AM)
(mean s.e.)
Control AM % of control: Tuimouir AM % of control
2256+109 100 1397+10lt 100
3312±1145 146 20064 192t 143
2268 1775
2819X±213
100
124
1448 1X157t
199514 221t
100
137
* 20 x 106 AM were incubated in HBSS containing 5 5 mm glucose with 12 5% pooled seruim from
either control or tumour-challenged animals in the presence of 0- 5 ,Ci 1-14C-glucose and with or without
heat-killed bacteria at 37°C for 60 min. Data were pooled from :3 experimental series with 12 rats per
group.
t P < 0-01 when compared to control AM values.
t % of the level in absence of bacteria.
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glucose oxidation during phagocytosis
was only 24% in the presence of serum
from tumour-challenged groups, which
was -500/ less than that seen in controls.
In contrast, AM from lung-tumour-bearing
animals showed a significant depression
in glucose oxidation relative to control
AM. This was consistently observed with
or without associated bacterial phago-
cytosis, although the response to bacterial
challenge was evident.
DISCUSSION
Non-specific stimulation of the reticulo-
endothelial system (RES) enhances host
resistance to tumour growth and tumour-
cell dissemination (Stern, 1960; Old et
al., 1961; Hanna, Zbar and Rapp, 1972)
while macrophage dysfunction has been
correlated with impaired anti-tumour im-
munity (Kampschmidt and Clabaugh,
1964; Saba and Antikatzides, 1976). The
neoplastic process itself has a deleterious
effect on RES function (Franchi et al.,
1972; Di Luzio, 1975; Saba and Anti-
katzides, 1975) clearly indicating that
the suppression of the macrophage, or
inability of the macrophage to become
activated, may be a critical event in
the dissemination and proliferation of
neoplastic cells. Thus, while compromised
macrophage function may be aetiologic
in the development of cancers, the growth
and spread of malignant disease may
feedback and undermine macrophage anti-
tumour activity and set in motion a
positive feedback cycle leading to host
deterioration.
In contrast to abundant studies cor-
relating stimulation of systemic RE func-
tion with increased tumour-cell killing,
the influence of tumour growth on local
pulmonary alveolar macrophage function
is not well documented. Modification of
innate lung defence mechanisms can in-
fluence the extent of lung-tumour growth
from blood-borne tumour cells. For
example, pulmonary metastatic tumour
growth from i.v. injected tumour cells
can be enhanced by local X-irradiation
of the lung (van den Brenk et al., 1973;
van den Brenk and Kelly, 1974) surgically
induced hepatic RE depression (Saba
and Antikatzides, 1976; van den Brenk
et al., 1976) pharmacologically induced
pulmonary inflammatory reactions (van
den Brenk et al., 1974) or i.v. injection
of potent cytostatic agents such as
cyclophosphamide (van Putten et al.,
1975; Carmel and Brown, 1977). Although
the mechanisms accelerating lung-tumour
growth after pulmonary injury are not
understood, such a response may be
mediated by an escape from non-specific
tumour-surveillance mechanisms.
The initial host-defence response of
the pulmonary RES to tumour-cell chal-
lenge appeared to be macrophage pro-
liferation, with no change in phagocytic
activity. However, the appearance of
macroscopic lung tumour nodules was
subsequently associated with depression
of AM activity. Optimal bacterial phago-
cytosis by AM appears dependent upon
humoral opsonic factors (Reynolds, Kaz-
mierowski and Newball, 1975) and the
maintenance of glucose metabolism for
the provision of metabolic energy (Ouchi,
Selvaraj and Sbarra, 1965). Our observa-
tion of reduced phagocytosis by AM
incubated in serum from tumour-bearing
animals, suggests that decreased serum
opsonic activity, and/or the presence
of a macrophage-inhibitory substance in
the serum, may be an additional factor
contributing to macrophage hypofunction
in response to lung-tuimour growth. The
previous demonstration that phasic
changes in RES phagocytic activity during
tumour growth were correlated with
circulating bioassayable opsonin activity,
as expressed by an ce-2-glycoprotein (Blu-
menstock et al., 1977; Saba and Anti-
katzides, 1975) supports the hypothesis
that alterations in opsonic recognition
factor may be involved. Depletion of
humoral opsonic or recognition factors
has been observed in cancer patients,
but the relationship of this event to
tumour immunity remains to be defined.
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following the a)pearaiice of lung tumour
nodules even in the presence of normal
serum, suggests that cellular metabolic
or membrane perturbations may be funda-
mental to the observed macrophage hypo-
function. Phagocytosis by AM is coupled
with stimulat,ion of glucose oxidation
(Gee et al., 1974) and increased transport
of glucose to provide an energy substrate
(Bonventre and Mukkada, 1974; Gudewicz
et al., 1976b). Therefore, a metabolic
disturbance of AM may precede overt
macrophage dysfunction as a result of
yet unknown macrophage and tumour-cell
interactions. Our study supports this
concept, in that AM glucose oxidationi
was depressed before the appearance of
macroscopic lung tumour nodules or
significant phagocytic impairment. TIhe
observation that serum from tumour-
bearing animals had no direct inhibitory
effect on AM glucose oxidation prior to
the addition of bacteria, suggests that
this is not mediated by a blood-borne
substance that inhibits glucose oxidation.
In contrast, the persistent depression in
pre- and post-phagocytic glucose oxida-
tion by macrophages harvested during
tumour growth, suggests that the neo-
plasm itself may have exerted a suppres-
sive influence in vivo on the AM. The
findings by Pike and Snyderman (1976) of
depressed macrophage chemotactic be-
haviour under the influence of a low-
mol.-wt heat-stable inhibitory factor iso-
lated from growing tumours in mice, lend
credence to this concept.
The present findings ofincreasedmacro-
phage content of the alveolar space
and altered macrophage physiological
behaviour with tumour growth, must
be considered with respect to the data
of Eccles, Bandlow and Alexander (1976)
and Eccles and Alexanider (1974). They
observed increased macrophage content
of growing tumours, which was related
to the degree of immunogenicity of the
tumour, and a parallel impairment of
monocyte ability to enter a site of
inflammation. Tumour growth following
transplantation, as investigated in rats
with 2 svugenieic transplanted sarcomas,
elicited a distinct monocytosis which
declined after surgical removal of the
tumour (Eccles et al., 1976). They pro-
posed that states of "immunological
anergy" with tumour growth may be
related to the lack of availability and
participation of macrophages in the in-
flammatory response, although the mech-
anism remains to be defined. Such findings
demonstrate another a,spect of altered
macrophage function that can result from
tumour growth.
Thus, the success of circulating tumour
cells or actively growing neoplasms to
undermine macrophage activities, may be
a significant neoplasm-induced local escape
mechanism which can compromise anti-
tumour host defence mechanisms. When
viewed with this perspective, surgical
removal of the neoplasm may provide
both an indirect and direct approach
to the limitations of tumour growth and
spread. Wlhen coupled with suipportive
immunotherapy to activate local macro-
phages and specific immune mechanisms
(McKneally, Maver and Kausel, 1976)
significant success may be achieved in
dealing with some lung tumours. Indeed,
some forms of immunotherapy adminis-
tered locally after lung-tumour resection
(McKneally et al., 1976) may actively
augment macrophage function, reversing
the negative effect of tumour growth.
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